Coagulation abnormalities in adults with cryptogenic stroke and patent foramen ovale

被引:52
作者
Chaturvedi, S [1 ]
机构
[1] Wayne State Univ, Detroit Med Ctr 6E UHC, Dept Neurol, Detroit, MI 48201 USA
关键词
stroke; ischemic; patent foramen ovale; anticardiolipin antibodies; activated protein C resistance; transesophageal echocardiography; cryptogenic;
D O I
10.1016/S0022-510X(98)00243-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A patent foramen ovale (PFO) is found by transesophageal echocardiography in one half of patients with cryptogenic stroke (CS). Coagulation abnormalities may promote paradoxical emboli in these patients. Seventeen patients were identified with PFO and CS. Thirty-one percent of patients had hematologic risk factors for venous thrombosis. These included abnormal activated protein C resistance and increased anticardiolipin antibodies. Patients with coagulation abnormalities and a PFO were three times as likely to be treated with warfarin compared to aspirin (P<0.05). Prothrombotic states are common in patients with PFO and CS and identifying these conditions may impact the choice of antithrombotic therapy. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:158 / 160
页数:3
相关论文
共 15 条
  • [1] CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL
    ADAMS, HP
    BENDIXEN, BH
    KAPPELLE, LJ
    BILLER, J
    LOVE, BB
    GORDON, DL
    MARSH, EE
    KASE, CS
    WOLF, PA
    BABIKIAN, VL
    LICATAGEHR, EE
    ALLEN, N
    BRASS, LM
    FAYAD, PB
    PAVALKIS, FJ
    WEINBERGER, JM
    TUHRIM, S
    RUDOLPH, SH
    HOROWITZ, DR
    BITTON, A
    MOHR, JP
    SACCO, RL
    CLAVIJO, M
    ROSENBAUM, DM
    SPARR, SA
    KATZ, P
    KLONOWSKI, E
    CULEBRAS, A
    CAREY, G
    MARTIR, NI
    FICARRA, C
    HOGAN, EL
    CARTER, T
    GURECKI, P
    MUNTZ, BK
    RAMIREZLASSEPAS, M
    TULLOCH, JW
    QUINONES, MR
    MENDEZ, M
    ZHANG, SM
    ALA, T
    JOHNSTON, KC
    ANDERSON, DC
    TARREL, RM
    NANCE, MA
    BUDLIE, SR
    DIERICH, M
    HELGASON, CM
    HIER, DB
    SHAPIRO, RA
    [J]. STROKE, 1993, 24 (01) : 35 - 41
  • [2] Barinagarrementeria F, 1998, NEUROLOGY, V50, pA155
  • [3] Stroke recurrence in patients with patent foramen ovale: The Lausanne Study
    Bogousslavsky, J
    Garazi, S
    Jeanrenaud, X
    Aebischer, N
    VanMelle, G
    [J]. NEUROLOGY, 1996, 46 (05) : 1301 - 1305
  • [4] DAHLBACK B, 1995, THROMB HAEMOSTASIS, V73, P739
  • [5] PATENT FORAMEN OVALE AS A RISK FACTOR FOR CRYPTOGENIC STROKE
    DITULLIO, M
    SACCO, RL
    GOPAL, A
    MOHR, JP
    HOMMA, S
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 117 (06) : 461 - 465
  • [6] DITULLIO MR, 1994, CIRCULATION, V90, P1
  • [7] PREVALENCE OF PATENT FORAMEN OVALE IN PATIENTS WITH STROKE
    LECHAT, P
    MAS, JL
    LASCAULT, G
    LORON, P
    THEARD, M
    KLIMCZAC, M
    DROBINSKI, G
    THOMAS, D
    GROSGOGEAT, Y
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (18) : 1148 - 1152
  • [8] Levine AB, 1996, CONTRACEPTION, V53, P255
  • [9] RECURRENT CEREBROVASCULAR EVENTS IN PATIENTS WITH PATENT FORAMEN OVALE, ATRIAL SEPTAL ANEURYSM, OR BOTH AND CRYPTOGENIC STROKE OR TRANSIENT ISCHEMIC ATTACK
    MAS, JL
    ZUBER, M
    [J]. AMERICAN HEART JOURNAL, 1995, 130 (05) : 1083 - 1088
  • [10] Mohr JP, 1997, CEREBROVASC DIS, V7, P100